We are developing new methodologies to simultaneously segment, measure tumor changes, and accumulate radiation treatment doses to treated tumors and organs to increase personalization of adaptive radiation treatments using cone-beam CT as well as new MRI-guided treatments applied to lung, prostate, and pancreatic cancers.